392 related articles for article (PubMed ID: 19932750)
1. Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro-in vivo evaluation in healthy human volunteers.
Tadros MI
Eur J Pharm Biopharm; 2010 Feb; 74(2):332-9. PubMed ID: 19932750
[TBL] [Abstract][Full Text] [Related]
2. Formulation and in vitro, in vivo evaluation of effervescent floating sustained-release imatinib mesylate tablet.
Kadivar A; Kamalidehghan B; Javar HA; Davoudi ET; Zaharuddin ND; Sabeti B; Chung LY; Noordin MI
PLoS One; 2015; 10(6):e0126874. PubMed ID: 26035710
[TBL] [Abstract][Full Text] [Related]
3. Formulation and evaluation of swellable and floating gastroretentive ciprofloxacin hydrochloride tablets.
Arza RA; Gonugunta CS; Veerareddy PR
AAPS PharmSciTech; 2009; 10(1):220-6. PubMed ID: 19277869
[TBL] [Abstract][Full Text] [Related]
4. In vitro characterization and release study of Ambroxol hydrochloride matrix tablets prepared by direct compression.
Abd-Elbary A; Haider M; Sayed S
Pharm Dev Technol; 2012; 17(5):562-73. PubMed ID: 21428699
[TBL] [Abstract][Full Text] [Related]
5. Formulation and evaluation of effervescent floating tablets of tizanidine hydrochloride.
Someshwar K; Chithaluru K; Ramarao T; Kumar KK
Acta Pharm; 2011 Jun; 61(2):217-26. PubMed ID: 21684848
[TBL] [Abstract][Full Text] [Related]
6. Development and in vivo floating behavior of verapamil HCl intragastric floating tablets.
Patel A; Modasiya M; Shah D; Patel V
AAPS PharmSciTech; 2009; 10(1):310-5. PubMed ID: 19296224
[TBL] [Abstract][Full Text] [Related]
7. Development of Multiple-Unit Floating Drug Delivery System of Clarithromycin: Formulation, in vitro Dissolution by Modified Dissolution Apparatus, in vivo Radiographic Studies in Human Volunteers.
Reddy AB; Reddy ND
Drug Res (Stuttg); 2017 Jul; 67(7):412-418. PubMed ID: 28449156
[TBL] [Abstract][Full Text] [Related]
8. Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl.
El Nabarawi MA; Teaima MH; Abd El-Monem RA; El Nabarawy NA; Gaber DA
Drug Des Devel Ther; 2017; 11():1081-1093. PubMed ID: 28435220
[TBL] [Abstract][Full Text] [Related]
9. Floating tablets for controlled release of ofloxacin via compression coating of hydroxypropyl cellulose combined with effervescent agent.
Qi X; Chen H; Rui Y; Yang F; Ma N; Wu Z
Int J Pharm; 2015 Jul; 489(1-2):210-7. PubMed ID: 25956047
[TBL] [Abstract][Full Text] [Related]
10. Effect of formulation parameters on the drug release and floating properties of gastric floating two-layer tablets with acetylsalicylic acid.
Hasçiçek C; Yüksel-Tilkan G; Türkmen B; Ozdemir N
Acta Pharm; 2011 Sep; 61(3):303-12. PubMed ID: 21945909
[TBL] [Abstract][Full Text] [Related]
11. The impact of polymers on 3D microstructure and controlled release of sildenafil citrate from hydrophilic matrices.
Krupa A; Tabor Z; Tarasiuk J; Strach B; Pociecha K; Wyska E; Wroński S; Łyszczarz E; Jachowicz R
Eur J Pharm Sci; 2018 Jul; 119():234-243. PubMed ID: 29679708
[TBL] [Abstract][Full Text] [Related]
12. Floating matrix dosage form for phenoporlamine hydrochloride based on gas forming agent: in vitro and in vivo evaluation in healthy volunteers.
Xu X; Sun M; Zhi F; Hu Y
Int J Pharm; 2006 Mar; 310(1-2):139-45. PubMed ID: 16413710
[TBL] [Abstract][Full Text] [Related]
13. Gastric floating matrix tablets: design and optimization using combination of polymers.
Prajapati ST; Patel LD; Patel DM
Acta Pharm; 2008 Jun; 58(2):221-9. PubMed ID: 18515232
[TBL] [Abstract][Full Text] [Related]
14. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology.
Huang YB; Tsai YH; Lee SH; Chang JS; Wu PC
Int J Pharm; 2005 Jan; 289(1-2):87-95. PubMed ID: 15652202
[TBL] [Abstract][Full Text] [Related]
15. Formulation and evaluation of different floating tablets containing metronidazole to target stomach.
Loh ZC; Elkordy AA
Curr Drug Deliv; 2015; 12(4):425-43. PubMed ID: 25924732
[TBL] [Abstract][Full Text] [Related]
16. Investigation and Evaluation of an in Situ Interpolymer Complex of Carbopol with Polyvinylpyrrolidone as a Matrix for Gastroretentive Tablets of Ranitidine Hydrochloride.
Yusif RM; Abu Hashim II; Mohamed EA; El Rakhawy MM
Chem Pharm Bull (Tokyo); 2016; 64(1):42-51. PubMed ID: 26726743
[TBL] [Abstract][Full Text] [Related]
17. In vitro release kinetics and bioavailability of gastroretentive cinnarizine hydrochloride tablet.
Nagarwal RC; Ridhurkar DN; Pandit JK
AAPS PharmSciTech; 2010 Mar; 11(1):294-303. PubMed ID: 20182827
[TBL] [Abstract][Full Text] [Related]
18. Design and evaluation of effervescent floating tablets based on hydroxyethyl cellulose and sodium alginate using pentoxifylline as a model drug.
Rahim SA; Carter PA; Elkordy AA
Drug Des Devel Ther; 2015; 9():1843-57. PubMed ID: 25848220
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of gastroretentive norfloxacin floating tablets.
Bomma R; Swamy Naidu RA; Yamsani MR; Veerabrahma K
Acta Pharm; 2009 Jun; 59(2):211-21. PubMed ID: 19564145
[TBL] [Abstract][Full Text] [Related]
20. Controlled release of the pineal hormone melatonin from hydroxypropylmethylcellulose/sodium alginate matrices in aqueous media containing dioctyl sulfosuccinate.
Vlachou M; Tsiakoulia A; Eikosipentaki A
Curr Drug Discov Technol; 2007 Jun; 4(1):31-8. PubMed ID: 17630926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]